Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5175771
Max Phase: Preclinical
Molecular Formula: C33H34N4O6
Molecular Weight: 582.66
Associated Items:
ID: ALA5175771
Max Phase: Preclinical
Molecular Formula: C33H34N4O6
Molecular Weight: 582.66
Associated Items:
Canonical SMILES: CO[C@@H]1[C@]2(O)c3cc(O)ccc3N3C(C)(C)[C@H](C)[C@]32N2C(=O)/C3=C/c4c([nH]c5ccccc45)C(C)(C)/C=C\N3C(=O)[C@]12O
Standard InChI: InChI=1S/C33H34N4O6/c1-17-30(4,5)36-23-12-11-18(38)15-21(23)31(41)27(43-6)32(42)28(40)35-14-13-29(2,3)25-20(19-9-7-8-10-22(19)34-25)16-24(35)26(39)37(32)33(17,31)36/h7-17,27,34,38,41-42H,1-6H3/b14-13-,24-16-/t17-,27+,31+,32+,33+/m0/s1
Standard InChI Key: MSTTUAKAQAEEGT-TZMKZJTPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 582.66 | Molecular Weight (Monoisotopic): 582.2478 | AlogP: 3.24 | #Rotatable Bonds: 1 |
Polar Surface Area: 129.57 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 9.75 | CX Basic pKa: | CX LogP: 3.86 | CX LogD: 3.86 |
Aromatic Rings: 3 | Heavy Atoms: 43 | QED Weighted: 0.35 | Np Likeness Score: 1.77 |
1. Liu L, Qian X, Yang T, Fang D, Qin Z, Ren B, Li G.. (2022) Cyclopiazonic Acid and Okaramine Analogues, Including Chlorinated Compounds, from Chrysosporium undulatum YT-1., 85 (11.0): [PMID:36268672] [10.1021/acs.jnatprod.2c00445] |
Source(1):